ESID
  • Users Online: 57
  • Print this page
  • Email this page

    Article Cited by others

EDITORIAL

Being realistic and optimistic in curing cancer

Naing Aung

Year : 2018| Volume: 1| Issue : 2 | Page no: 53-55

   This article has been cited by
 
1 The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
Lihu Gu,Parikshit Asutosh Khadaroo,Hui Su,Liya Kong,Liangliang Chen,Xianfa Wang,Xinlong Li,Hepan Zhu,Xin Zhong,Junhai Pan,Manman Chen
BMC Cancer. 2019; 19(1)
[Pubmed]  [Google Scholar] [DOI]
2 Optimizing Precision Oncology and Immunotherapy Strategies: Moving into the Next Stage of Cancer Medicine
Phoebe Lewis,TimothyA Yap
Journal of Immunotherapy and Precision Oncology. 2019; 2(1): 1
[Pubmed]  [Google Scholar] [DOI]
3 Opening new boundaries in biomarker detection: Awakening of middle east and North Africa Region
Christian Rolfo,Umberto Malapelle
Journal of Immunotherapy and Precision Oncology. 2019; 2(1): 8
[Pubmed]  [Google Scholar] [DOI]
4 Tackling immunotherapy resistance: Developing rational combinations of immunotherapy and targeted drugs
Elena Cojocaru,Mariana Scaranti,Anna Minchom
Journal of Immunotherapy and Precision Oncology. 2019; 2(2): 23
[Pubmed]  [Google Scholar] [DOI]

 

Read this article